| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 874.56 Million | USD 1,802.50 Million | 7.50% | 2024 |
FrequentlyAsked Questions
Biological buffers are organic elements used for maintaining a constant pH level in a biological system.
The global biological buffer market is expected to be driven by the increasing use of the substances in the biopharmaceutical industry.
According to study, the global biological buffers market size was worth around USD 874.56 million in 2024 and is predicted to grow to around USD 1,802.50 million by 2034.
The CAGR value of the biological buffers market is expected to be around 7.50% during 2025-2034.
The global biological buffers market will be led by Europe during the forecast period.
The global biological buffers market is led by players like BASF SE, Merck KGaA, Hamilton Company, Molecular Depot LLC, Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., Boston BioProducts, Bio-Rad Laboratories, Inc., Leinco Technologies, GE Healthcare, Biomiga, Inc., Avantor, Hopax Fine Chemicals, Lonza Group Ltd., and F. Hoffmann-La Roche Ltd.
The report explores crucial aspects of the biological buffers market, including a detailed discussion of existing growth factors and restraints, while browsing future growth opportunities and challenges that impact the market.
HappyClients